Skip to main content

BRIEF RESEARCH REPORT article

Front. Pediatr.
Sec. Pediatric Rheumatology
Volume 12 - 2024 | doi: 10.3389/fped.2024.1428644
This article is part of the Research Topic Building a Learning Health System in Pediatric Rheumatology View all 6 articles

Improving Lupus Care Index Documentation in Childhood-Onset Systemic Lupus Erythematosus

Provisionally accepted
  • 1 Amgen (United States), Thousand Oaks, United States
  • 2 Baylor College of Medicine, Houston, Texas, United States
  • 3 Nationwide Children's Hospital, Columbus, Ohio, United States
  • 4 King Saud University Medical City, Riyadh, Saudi Arabia

The final, formatted version of the article will be published soon.

    Improving Lupus Care Index Documentation in Children with Childhood-onset Systemic Lupus Erythematosus (c-SLE), aligns closely with the scope of Frontiers in Pediatric Rheumatology, which emphasizes advances in clinical practices for pediatric Rheumatic Diseases. Our study details a Quality Improvement (QI) initiative at Nationwide Children's Hospital aimed at enhancing the documentation of disease assessment in patients with c-SLE. This work is directly relevant to the journal's focus on innovative methodologies and improved outcomes in pediatric rheumatology. By showcasing effective strategies for accurate disease assessment through a multidisciplinary approach, our manuscript offers valuable insights that can advance the management of pediatric lupus, aligning well with the journal's commitment to high-impact pediatric research.

    Keywords: Data curation, Software, Writing -review & editing. Cagri Yildirim-Toruner: Conceptualization, project administration, Writing -review & editing. Edward Oberle: Conceptualization, methodology, Writing -review & editing. Fatima A Barbar-Smiley: Conceptualization, Formal analysis

    Received: 06 May 2024; Accepted: 01 Aug 2024.

    Copyright: © 2024 Barbar-Smiley, Yildirim Toruner, Akoghlanian, Al Ahmed, Ardoin, Leone, Oberle and Sivaraman. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Fatima A. Barbar-Smiley, Amgen (United States), Thousand Oaks, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.